Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 1
1997 1
2008 2
2011 1
2012 1
2013 1
2015 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Wilms' tumor.
Warrier RP, Regueira O. Warrier RP, et al. Among authors: regueira o. Pediatr Nephrol. 1992 Jul;6(4):358-64. doi: 10.1007/BF00869738. Pediatr Nephrol. 1992. PMID: 1323319 Review.
Treatment of juvenile xanthogranuloma.
Stover DG, Alapati S, Regueira O, Turner C, Whitlock JA. Stover DG, et al. Among authors: regueira o. Pediatr Blood Cancer. 2008 Jul;51(1):130-3. doi: 10.1002/pbc.21523. Pediatr Blood Cancer. 2008. PMID: 18338395 Review.
Current treatment and prognosis of Wilms' tumor.
Regueira O, Warrier RP, Yu LC, Ode DL. Regueira O, et al. Indian J Pediatr. 1993 Jul-Aug;60(4):551-8. doi: 10.1007/BF02751433. Indian J Pediatr. 1993. PMID: 8262591 Review.
Bone marrow transplant in Shwachman Diamond syndrome.
Barrios N, Kirkpatrick D, Regueira O, Wuttke B, McNeil J, Humbert J. Barrios N, et al. Among authors: regueira o. Br J Haematol. 1991 Oct;79(2):337-8. doi: 10.1111/j.1365-2141.1991.tb04545.x. Br J Haematol. 1991. PMID: 1958495 No abstract available.
N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children: translational pharmacokinetics.
Hanly LN, Chen N, Aleksa K, Cutler M, Bajcetic M, Palassery R, Regueira O, Turner C, Baw B, Malkin B, Freeman D, Rieder MJ, Vasylyeva TL, Koren G. Hanly LN, et al. Among authors: regueira o. J Clin Pharmacol. 2012 Jan;52(1):55-64. doi: 10.1177/0091270010391790. Epub 2011 Jan 24. J Clin Pharmacol. 2012. PMID: 21263015 Clinical Trial.
11 results